Myopathic Ehlers-Danlos Syndrome (mEDS) Related to COL12A1: Two Novel Families and Literature Review
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Luciano Merlini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Neuromotor Science, University of Bologna, DIBINEM, 40136 Bologna, Italy. Hauptthemen laut MEDLINE: Collagen Type XII, Ehlers-Danlos Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Reference Network NMD, and the “Solve-RD Project”, Italian Ministry of University and Research.
Abstract (Originalsprache)
Myopathic Ehlers-Danlos syndrome (RmEDS) is an emerging hybrid phenotype that combines connective and muscle tissue abnormalities. It has been associated with variants of the COL12A1 gene, which are known as Ullrich congenital muscular dystrophy-2 (UCMD2; 616470) and Bethlem myopathy-2 (BTHLM2; 616471). Here, we report two splicing mutations of COL12A1 identified in three patients from two unrelated families who present a combination of joint hypermobility and axial, distal, and proximal weakness. The muscular strength of their neck and limb muscles was assessed at 4/5 (MRC); however, when measured with a myometer, the expected percentage by age and sex ranged from 35% to 40% for elbow flexion, 37% to 75% for knee extension, and was 50% for neck flexion. In addition to confirming the characteristic atrophy of the rectus femoris, we presented evidence of involvement of the neck and lumbar muscles through MRI and CT imaging. In vitro studies revealed filamentous disorganization and an altered pattern of collagen XII alpha 1 chain migration due to the skipping of exons 55 and 56 of collagen XII. Additionally, we review the myopathic involvement of COL12-RM in 30 patients across 18 families with dominant mutations and 15 patients from 13 families with recessive mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical and Neuromotor Science, University of Bologna, DIBINEM, 40136 Bologna, Italy.
- CNR-Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", Via di Barbiano 1/10, 40136 Bologna, Italy.
- IRCCS, Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136 Bologna, Italy.
- Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 7, 80138 Naples, Italy.
- Ist Orthopedic Department, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
- Ortopedia-Traumatologia e Chirurgia Protesica e dei Reimpianti d'anca e di Ginocchio, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
ORCID-Profile: Luciano Merlini, Vittoria Cenni, Mariateresa Zanobio, Alberto Di Martino, Francesco Traina, Annalaura Torella
Förderung
- European Reference Network NMD, and the “Solve-RD Project”
- Italian Ministry of University and Research
Zitieren
APA
Merlini, L., Sabatelli, P., Cenni, V., Zanobio, M., Di Martino, A., Traina, F., Faldini, C., Nigro, V., & Torella, A. (2025). Myopathic Ehlers-Danlos Syndrome (mEDS) Related to COL12A1: Two Novel Families and Literature Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115387
Vancouver
Merlini L, Sabatelli P, Cenni V, Zanobio M, Di Martino A, Traina F, et al. Myopathic Ehlers-Danlos Syndrome (mEDS) Related to COL12A1: Two Novel Families and Literature Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115387
BibTeX
@article{Merlini2025,
author = {Merlini, Luciano and Sabatelli, Patrizia and Cenni, Vittoria and Zanobio, Mariateresa and Di Martino, Alberto and Traina, Francesco and Faldini, Cesare and Nigro, Vincenzo and Torella, Annalaura},
title = {Myopathic Ehlers-Danlos Syndrome (mEDS) Related to COL12A1: Two Novel Families and Literature Review},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115387}
}
EUVIMED